Cargando…

Transcriptional reprogramming of metabolic pathways in critically ill patients

BACKGROUND: Critical illness causes a shift away from mitochondrial metabolism towards a greater dependence on glycolysis. This metabolic shift is thought to be associated with lactic acidosis, organ dysfunction and poor clinical outcomes. The current paradigm is that low oxygen supply causes region...

Descripción completa

Detalles Bibliográficos
Autores principales: Nalos, Marek, Parnell, Grant, Robergs, Robert, Booth, David, McLean, Anthony S., Tang, Benjamin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936987/
https://www.ncbi.nlm.nih.gov/pubmed/27387528
http://dx.doi.org/10.1186/s40635-016-0094-1
_version_ 1782441626698776576
author Nalos, Marek
Parnell, Grant
Robergs, Robert
Booth, David
McLean, Anthony S.
Tang, Benjamin M.
author_facet Nalos, Marek
Parnell, Grant
Robergs, Robert
Booth, David
McLean, Anthony S.
Tang, Benjamin M.
author_sort Nalos, Marek
collection PubMed
description BACKGROUND: Critical illness causes a shift away from mitochondrial metabolism towards a greater dependence on glycolysis. This metabolic shift is thought to be associated with lactic acidosis, organ dysfunction and poor clinical outcomes. The current paradigm is that low oxygen supply causes regional hypoxia, which in turn drives such a metabolic shift. In this study, we evaluated whether the shift towards glycolysis can also occur in cells where oxygen supply is plentiful. METHODS: We used circulating blood cells from non-hypoxic critically ill patients (n = 47) as a model to study cellular metabolism in a normal oxygen milieu. We measured the transcriptomic profiles of canonical metabolic pathways in these cells and compared them to cells obtained from healthy controls (n = 18). RESULTS: Transcriptomic profiling revealed a significant reprogramming of metabolic pathways during critical illness. In well-oxygenated cells, there was a reduced expression of tricarboxylic acid cycle genes and genes associated with pyruvate entry into the mitochondria suggesting decreased mitochondrial oxidation. In contrast, glycolysis was accelerated, as reflected by an up-regulation of genes coding for enzymes of early and late glycolytic pathway that were associated with increased lactate production. The pentose phosphate pathway genes for NADPH production were also up-regulated suggesting enhanced antioxidant production during increased oxidative stress. CONCLUSIONS: Contrary to the established paradigm, aerobic glycolysis does occur in non-hypoxic cells during critical illness and its occurrence may represent an adaptive strategy common to cells under increased oxidative stress. Further study of this previously under-recognized metabolic phenomenon might identify novel drug target for antioxidant therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40635-016-0094-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4936987
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-49369872016-07-08 Transcriptional reprogramming of metabolic pathways in critically ill patients Nalos, Marek Parnell, Grant Robergs, Robert Booth, David McLean, Anthony S. Tang, Benjamin M. Intensive Care Med Exp Research BACKGROUND: Critical illness causes a shift away from mitochondrial metabolism towards a greater dependence on glycolysis. This metabolic shift is thought to be associated with lactic acidosis, organ dysfunction and poor clinical outcomes. The current paradigm is that low oxygen supply causes regional hypoxia, which in turn drives such a metabolic shift. In this study, we evaluated whether the shift towards glycolysis can also occur in cells where oxygen supply is plentiful. METHODS: We used circulating blood cells from non-hypoxic critically ill patients (n = 47) as a model to study cellular metabolism in a normal oxygen milieu. We measured the transcriptomic profiles of canonical metabolic pathways in these cells and compared them to cells obtained from healthy controls (n = 18). RESULTS: Transcriptomic profiling revealed a significant reprogramming of metabolic pathways during critical illness. In well-oxygenated cells, there was a reduced expression of tricarboxylic acid cycle genes and genes associated with pyruvate entry into the mitochondria suggesting decreased mitochondrial oxidation. In contrast, glycolysis was accelerated, as reflected by an up-regulation of genes coding for enzymes of early and late glycolytic pathway that were associated with increased lactate production. The pentose phosphate pathway genes for NADPH production were also up-regulated suggesting enhanced antioxidant production during increased oxidative stress. CONCLUSIONS: Contrary to the established paradigm, aerobic glycolysis does occur in non-hypoxic cells during critical illness and its occurrence may represent an adaptive strategy common to cells under increased oxidative stress. Further study of this previously under-recognized metabolic phenomenon might identify novel drug target for antioxidant therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40635-016-0094-1) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-07-07 /pmc/articles/PMC4936987/ /pubmed/27387528 http://dx.doi.org/10.1186/s40635-016-0094-1 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Research
Nalos, Marek
Parnell, Grant
Robergs, Robert
Booth, David
McLean, Anthony S.
Tang, Benjamin M.
Transcriptional reprogramming of metabolic pathways in critically ill patients
title Transcriptional reprogramming of metabolic pathways in critically ill patients
title_full Transcriptional reprogramming of metabolic pathways in critically ill patients
title_fullStr Transcriptional reprogramming of metabolic pathways in critically ill patients
title_full_unstemmed Transcriptional reprogramming of metabolic pathways in critically ill patients
title_short Transcriptional reprogramming of metabolic pathways in critically ill patients
title_sort transcriptional reprogramming of metabolic pathways in critically ill patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4936987/
https://www.ncbi.nlm.nih.gov/pubmed/27387528
http://dx.doi.org/10.1186/s40635-016-0094-1
work_keys_str_mv AT nalosmarek transcriptionalreprogrammingofmetabolicpathwaysincriticallyillpatients
AT parnellgrant transcriptionalreprogrammingofmetabolicpathwaysincriticallyillpatients
AT robergsrobert transcriptionalreprogrammingofmetabolicpathwaysincriticallyillpatients
AT boothdavid transcriptionalreprogrammingofmetabolicpathwaysincriticallyillpatients
AT mcleananthonys transcriptionalreprogrammingofmetabolicpathwaysincriticallyillpatients
AT tangbenjaminm transcriptionalreprogrammingofmetabolicpathwaysincriticallyillpatients